These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19552638)

  • 61. Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin.
    Blank M; Cines DB; Arepally G; Eldor A; Afek A; Shoenfeld Y
    Clin Exp Immunol; 1997 May; 108(2):333-9. PubMed ID: 9158107
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Heparin-induced thrombocytopenia: towards standardization of platelet factor 4/heparin antigen tests.
    Greinacher A; Ittermann T; Bagemühl J; Althaus K; Fürll B; Selleng S; Lubenow N; Schellong S; Sheppard JI; Warkentin TE
    J Thromb Haemost; 2010 Sep; 8(9):2025-31. PubMed ID: 20626620
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery.
    Bennett-Guerrero E; Slaughter TF; White WD; Welsby IJ; Greenberg CS; El-Moalem H; Ortel TL
    J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1567-72. PubMed ID: 16308000
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4.
    Litvinov RI; Yarovoi SV; Rauova L; Barsegov V; Sachais BS; Rux AH; Hinds JL; Arepally GM; Cines DB; Weisel JW
    J Biol Chem; 2013 Nov; 288(46):33060-70. PubMed ID: 24097975
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
    Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
    Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Relationship between plasma homocysteine levels and saphenous vein graft disease after coronary artery bypass grafts.
    Iwama Y; Mokuno H; Watanabe Y; Shimada K; Yokoi H; Daida H; Hosoda Y; Yamaguchi H
    Jpn Heart J; 2001 Sep; 42(5):553-62. PubMed ID: 11804297
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study.
    Selleng S; Selleng K; Friesecke S; Gründling M; Kuhn SO; Raschke R; Heidecke OJ; Hinz C; Hron G; Warkentin TE; Greinacher A
    J Thromb Thrombolysis; 2015 Jan; 39(1):60-7. PubMed ID: 25002339
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT?
    Warkentin TE; Smythe MA; Ali MA; Aslam N; Sheppard JI; Smith JW; Moore JC; Arnold DM; Nazy I
    Am J Hematol; 2021 Mar; 96(3):320-329. PubMed ID: 33326124
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
    Huynh A; Arnold DM; Kelton JG; Smith JW; Horsewood P; Clare R; Guarné A; Nazy I
    J Thromb Haemost; 2019 Feb; 17(2):389-399. PubMed ID: 30582672
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Induction of anti-PF4/heparin antibodies after arthroplasty for rheumatic diseases.
    Migita K; Asano T; Sato S; Motokawa S
    Fukushima J Med Sci; 2018 Apr; 64(1):1-8. PubMed ID: 29628468
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Patency of conduits in patients who received internal mammary artery, radial artery and saphenous vein grafts.
    Royse A; Pamment W; Pawanis Z; Clarke-Errey S; Eccleston D; Ajani A; Wilson W; Canty D; Royse C
    BMC Cardiovasc Disord; 2020 Mar; 20(1):148. PubMed ID: 32204693
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ticagrelor for patients undergoing coronary artery bypass grafting: A meta-analysis of randomized controlled trials.
    Xiang F; Lin Y; Chen B
    Perfusion; 2023 May; 38(4):698-705. PubMed ID: 35403510
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
    Gao G; Zheng Z; Pi Y; Lu B; Lu J; Hu S
    J Am Coll Cardiol; 2010 Nov; 56(20):1639-43. PubMed ID: 21050973
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis.
    Look KA; Sahud M; Flaherty S; Zehnder JL
    Am J Clin Pathol; 1997 Jul; 108(1):78-82. PubMed ID: 9208982
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia.
    Huynh A; Kelton JG; Arnold DM; Daka M; Nazy I
    Nature; 2021 Aug; 596(7873):565-569. PubMed ID: 34233346
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia.
    Izban KF; Lietz HW; Hoppensteadt DA; Jeske WP; Fareed J; Bakhos M; Walenga JM
    Semin Thromb Hemost; 1999; 25 Suppl 1():51-6. PubMed ID: 10357152
    [TBL] [Abstract][Full Text] [Related]  

  • 77. External stenting of vein grafts in coronary artery bypass grating: interim results from a two centers prospective study.
    Weltert LP; Audisio K; Bellisaro A; Bardi G; Flocco R; De Paulis R; Centofanti P
    J Cardiothorac Surg; 2021 Apr; 16(1):74. PubMed ID: 33845865
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia.
    Alberio L; Kimmerle S; Baumann A; Taleghani BM; Biasiutti FD; Lämmle B
    Am J Med; 2003 May; 114(7):528-36. PubMed ID: 12753876
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells.
    Blank M; Shoenfeld Y; Tavor S; Praprotnik S; Boffa MC; Weksler B; Walenga MJ; Amiral J; Eldor A
    Int Immunol; 2002 Feb; 14(2):121-9. PubMed ID: 11809731
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Heparin-dependent and -independent anti-platelet factor 4 autoantibodies in patients with systemic lupus erythematosus.
    Satoh T; Tanaka Y; Okazaki Y; Kaburaki J; Ikeda Y; Kuwana M
    Rheumatology (Oxford); 2012 Sep; 51(9):1721-8. PubMed ID: 22718864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.